Intuitive Surgical, Inc. $ISRG Shares Acquired by Natixis Advisors LLC

Natixis Advisors LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.4% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 511,913 shares of the medical equipment provider’s stock after acquiring an additional 39,563 shares during the period. Natixis Advisors LLC’s holdings in Intuitive Surgical were worth $289,927,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of ISRG. Holos Integrated Wealth LLC acquired a new position in Intuitive Surgical during the fourth quarter worth approximately $25,000. Newbridge Financial Services Group Inc. increased its position in Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares during the last quarter. Greykasell Wealth Strategies Inc. acquired a new position in Intuitive Surgical during the third quarter worth approximately $27,000. Olistico Wealth LLC acquired a new position in Intuitive Surgical during the fourth quarter worth approximately $28,000. Finally, Caitlin John LLC acquired a new position in Intuitive Surgical during the third quarter worth approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 105 shares of the stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total transaction of $51,864.75. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 2,362 shares of the stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total transaction of $1,177,882.16. Following the transaction, the senior vice president owned 3,554 shares in the company, valued at $1,772,308.72. This trade represents a 39.93% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 4,833 shares of company stock valued at $2,357,582. 0.60% of the stock is owned by insiders.

Intuitive Surgical Trading Down 2.9%

Shares of ISRG stock opened at $412.26 on Tuesday. The company has a market capitalization of $146.01 billion, a PE ratio of 49.97, a price-to-earnings-growth ratio of 3.39 and a beta of 1.46. The firm has a fifty day simple moving average of $452.19 and a 200-day simple moving average of $504.81. Intuitive Surgical, Inc. has a twelve month low of $411.83 and a twelve month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business’s quarterly revenue was up 23.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.81 earnings per share. Equities research analysts predict that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on ISRG shares. Mizuho set a $525.00 price target on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research report on Monday, April 13th. UBS Group dropped their price target on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research report on Tuesday, March 17th. Citigroup raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target for the company in a research report on Wednesday, March 11th. BTIG Research reissued a “buy” rating and issued a $574.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, April 22nd. Finally, Piper Sandler dropped their price objective on shares of Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Nineteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $576.71.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.